CUMYL-BC-HPMEGACLONE-221

CUMYL-BC-HPMEGACLONE-221 is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that interact with the cannabinoid receptors in the endocannabinoid system.
Chemical Structure and Properties[edit]
CUMYL-BC-HPMEGACLONE-221 is chemically related to other synthetic cannabinoids. Its structure includes a cumyl group attached to a benzimidazole core, which is further connected to a cyclohexylmethyl side chain. The exact molecular formula and detailed chemical properties are essential for understanding its pharmacological effects and potential risks.
Pharmacology[edit]
As a synthetic cannabinoid, CUMYL-BC-HPMEGACLONE-221 acts on the CB1 and CB2 receptors in the endocannabinoid system. These receptors are primarily found in the central nervous system and immune system, respectively. The interaction with these receptors can lead to various psychoactive effects, including euphoria, altered perception, and relaxation.
Legal Status[edit]
The legal status of CUMYL-BC-HPMEGACLONE-221 varies by country. In some regions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. It is important to consult local regulations to determine its legal status.
Health Risks and Safety[edit]
The use of synthetic cannabinoids like CUMYL-BC-HPMEGACLONE-221 can pose significant health risks. Adverse effects may include tachycardia, hypertension, hallucinations, and psychosis. Long-term use can lead to dependence and withdrawal symptoms. Due to the potential for severe side effects, caution is advised when encountering this substance.
Detection and Analysis[edit]
Detection of CUMYL-BC-HPMEGACLONE-221 in biological samples can be challenging due to its synthetic nature and the constant evolution of new analogs. Advanced analytical techniques such as mass spectrometry and gas chromatography are often employed to identify and quantify this compound in forensic and clinical settings.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
